Lesico Ltd (TLV:LSCO)

Market Cap	181.51M
Revenue (ttm)	1.09B
Net Income (ttm)	15.52M
Shares Out	50.94M
EPS (ttm)	0.29
PE Ratio	12.20
Forward PE	n/a
Dividend	0.20 (5.43%)
Ex-Dividend Date	Apr 21, 2025

Volume	802
Average Volume	12,821
Open	361.40
Previous Close	361.40
Day's Range	355.20 - 361.40
52-Week Range	256.10 - 440.00
Beta	0.52
RSI	42.88
Earnings Date	Aug 24, 2025

About Sage Therapeutics

Lesico Ltd, together with its subsidiaries, engages in the construction of various infrastructure projects in Israel and internationally. The company operates through two segments, Construction and Maintenance. It coordinates the construction of civil engineering projects, including various buildings, and infrastructures above and below the ground; administrative and operational structures, such as protected structures and obstacles on the borders for the defense establishment; and rail infrastructure, such as laying tracks and related works. T...

• Industry: Engineering & Construction
• Sector: Industrials
• Founded: 1969
• Employees: 593
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: LSCO

Financial Performance

In 2024, Lesico's revenue was 1.04 billion, an increase of 29.73% compared to the previous year's 803.70 million. Earnings were 19.95 million, an increase of 122.95%.